Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)
Go back to Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)| TELEFLEX INCORPORATED (NYSE: TFX) | Delayed: 127.22 +2.96 (2.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.26 | 52 Week High | $188.79 | |||
| Open | $124.77 | 52 Week Low | $125.28 | |||
| Day High | $127.61 | P/E | 36.77 | |||
| Day Low | $124.77 | EPS | $3.46 | |||
| Volume | 22,255 | |||||
